Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
FDA Grants Orphan Drug Designation to GC Biopharma's Drug Candidate for Thrombotic Thrombocytopenic Purpura 2023-10-06 08:12
GC Biopharma to organize "Donate Blood with Love", a healthy way of giving back to the community 2023-08-30 16:05
GC Biopharma to Produce Cholera Vaccines Jointly with Eubiologics 2023-08-25 15:14
Thrombotic AEs of Hemlibra (emicizumab) were 2.8 times more frequent than those of FVIII replacements. 2023-08-18 08:58
U.S. FDA Accepts Biologics License Application for GC Biopharma's GC5107B (Immune Globulin Intravenous (Human), 10% Liquid) 2023-07-31 13:20
GC Biopharma's "GC FLU" obtains vaccine approval in Egypt: First-ever approval of the company's quadrivalent flu vaccine on the African continent 2023-07-21 16:47
GC Biopharma receives a business license for the construction of a plasma fractionation plant and technology transfer in Indonesia 2023-06-02 08:35
GC Biopharma celebrates 'World Hemophilia Day' 2023-04-18 09:03
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology 2023-02-28 08:53
GC Biopharma Receives WHO Pre-Qualification for BARYCELA 2023-02-20 09:38
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea 2023-02-09 09:21
GC Biopharma and Speragen Sponsored an Externally Led - Patient Focused Drug Development with FDA Attendance 2022-08-31 08:33
GC Pharma lights up to celebrate 'World Hemophilia Day' 2020-04-17 21:00
GC Pharma Reports Full Year 2019 Results 2020-02-12 22:00
GC Pharma Reports Q3 2019 Results 2019-10-30 21:00
GC Pharma Reports Q2 2019 Results 2019-07-30 22:31
GC Pharma Reports Q1 2019 Results 2019-04-30 15:37
Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug 2019-04-04 11:38
GC Pharma Reports Full Year 2018 Results 2019-02-12 22:00
GC Pharma Reports Q3 2018 Results 2018-10-30 16:33
1 2 3